Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D3 and is required for optimal cell differentiation

Experimental Cell Research

Volumn 313, Issue 14, 2007, Pages 3034-3045

  Wang, Xuening ^a   Wang, Tian Tian ^b   White, John H ^b   Studzinski, George P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Differentiation; KSR; Ras signaling; siRNA; Vitamin D; Vitamin D receptor

Indexed keywords

1,3,24 TRIHYDROXY 26,27 CYCLO 9,10 SECOCHOLESTA 5,7,10(19),22 TETRAENE 25 CARBOXYLIC ACID BUTYL ESTER; ALCOHOL; CALCITRIOL; CYCLOHEXIMIDE; DACTINOMYCIN; HUMAN KINASE SUPPRESSOR OF RAS 2 PROTEIN; ONCOPROTEIN; RETINOID X RECEPTOR ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR ANTAGONIST;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR MECHANICS; MONOCYTE; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN MOTIF; PROTEIN TARGETING; VITAMIN D METABOLISM;

EID: 34547159410     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.05.021     Document Type: Article

References (67)

1. MacDonald P.N., Haussler C.A., Terpening C.M., Galligan M.A., Reeder M.C., Whitfield G.K., and Haussler M.R. Baculovirus-mediated expression of the human vitamin D receptor. Functional characterization, vitamin D response element interactions, and evidence for a receptor auxiliary factor. J. Biol. Chem. 266 (1991) 18808-18813
2. Jones G., Strugnell S.A., and DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 78 (1998) 1193-1231
3. Jurutka P.W., Whitfield G.K., Hsieh J.C., Thompson P.D., Haussler C.A., and Haussler M.R. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev. Endocr. Metab. Disord. 2 (2001) 203-216
4. Jurutka P.W., MacDonald P.N., Nakajima S., Hsieh J.C., Thompson P.D., Whitfield G.K., Galligan M.A., Haussler C.A., and Haussler M.R. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor. J. Cell. Biochem. 85 (2002) 435-457
5. Markose E.R., Stein J.L., Stein G.S., and Lian J.B. Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1701-1705
6. Noda M., Vogel R.L., Craig A.M., Prahl J., DeLuca H.F., and Denhardt D.T. Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 9995-9999
7. Ozono K., Liao J., Kerner S.A., Scott R.A., and Pike J.W. The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J. Biol. Chem. 265 (1990) 21881-21888
8. Breen E.C., van Wijnen A.J., Lian J.B., Stein G.S., and Stein J.L. In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12902-12906
9. 3 24-hydroxylase gene. J. Biol. Chem. 271 (1996) 30381-30385
10. Therrien M., Chang H.C., Solomon N.M., Karim F.D., Wassarman D.A., and Rubin G.M. KSR, a novel protein kinase required for RAS signal transduction. Cell 83 (1995) 879-888
11. Kornfeld K., Hom D.B., and Horvitz H.R. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans. Cell 83 (1995) 903-913
12. Therrien M., Michaud N.R., Rubin G.M., and Morrison D.K. KSR modulates signal propagation within the MAPK cascade. Genes Dev. 10 (1996) 2684-2695
13. Roy F., and Therrien M. MAP kinase module: the Ksr connection. Curr. Biol. 12 (2002) R325-R327
14. Kortum R.L., Costanzo D.L., Haferbier J., Schreiner S.J., Razidlo G.L., Wu M.H., Volle D.J., Mori T., Sakaue H., Chaika N.V., Chaika O.V., and Lewis R.E. The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis. Mol. Cell. Biol. 25 (2005) 7592-7604
15. Lin R., and White J.H. The pleiotropic actions of vitamin D. BioEssays 26 (2004) 21-28
16. Studzinski G.P., Wang X., Ji Y., Wang Q., Zhang Y., Kutner A., and Harrison J.S. The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway. J. Steroid Biochem. Mol. Biol. 97 (2005) 47-55
17. 3 in human leukemia HL60 cells through a vitamin D response element in the 5′-flanking region. Oncogene 25 (2006) 7078-7085
18. Studzinski G.P., Garay E., Patel R., Zhang J., and Wang X. Vitamin D receptor signaling of monocytic differentiation in human leukemia cells: role of MAPK pathways in transcription factor activation. Curr. Top. Med. Chem. 6 (2006) 1267-1271
19. Morrison D.K. KSR: a MAPK scaffold of the Ras pathway?. J. Cell. Sci. 114 (2001) 1609-1612
20. Kolesnick R., and Xing H.R. Inflammatory bowel disease reveals the kinase activity of KSR1. J. Clin. Invest. 114 (2004) 1233-1237
21. Zhang Y., Yao B., Delikat S., Bayoumy S., Lin X.H., Basu S., McGinley M., Chan-Hui P.Y., Lichenstein H., and Kolesnick R. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89 (1997) 63-72
22. Xing H.R., and Kolesnick R. Kinase suppressor of Ras signals through Thr269 of c-Raf-1. J. Biol. Chem. 276 (2001) 9733-9741
23. Yan F., and Polk D.B. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells. Cancer Res. 61 (2001) 963-969
24. Xing H.R., Campodonico L., and Kolesnick R. The kinase activity of kinase suppressor of Ras1 (KSR1) is independent of bound MEK. J. Biol. Chem. 279 (2004) 26210-26214
25. Michaud N.R., Therrien M., Cacace A., Edsall L.C., Spiegel S., Rubin G.M., and Morrison D.K. KSR stimulates Raf-1 activity in a kinase-independent manner. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12792-12796
26. Morrison D.K., and Davis R.J. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19 (2003) 91-118
27. Takai Y., Sasaki T., and Matozaki T. Small GTP-binding proteins. Physiol. Rev. 81 (2001) 153-208
28. Ebisuya M., Kondoh K., and Nishida E. The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J. Cell. Sci. 118 (2005) 2997-3002
29. 3. J. Cell. Physiol. 198 (2004) 333-342
30. 3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK module. J. Cell. Physiol. 209 (2006) 253-260
31. Ohmachi M., Rocheleau C.E., Church D., Lambie E., Schedl T., and Sundaram M.V. C. elegans ksr-1 and ksr-2 have both unique and redundant functions and are required for MPK-1 ERK phosphorylation. Curr. Biol. 12 (2002) 427-433
32. Channavajhala P.L., Wu L., Cuozzo J.W., Hall J.P., Liu W., Lin L.L., and Zhang Y. Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling. J. Biol. Chem. 278 (2003) 47089-47097
33. Channavajhala P.L., Rao V.R., Spaulding V., Lin L.L., and Zhang Y.G. hKSR-2 inhibits MEKK3-activated MAP kinase and NF-kappaB pathways in inflammation. Biochem. Biophys. Res. Commun. 334 (2005) 1214-1218
34. Zhang Y., Zhang J., and Studzinski G.P. AKT pathway is activated by 1, 25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells. Cell Cycle 5 (2006) 447-451
35. 3. Cancer Res. 66 (2006) 4402-4409
36. 3. Exp. Cell Res. 312 (2006) 2054-2065
37. Gallagher R., Collins S., Trujillo J., McCredie K., Ahearn M., Tsai S., Metzgar R., Aulakh G., Ting R., Ruscetti F., and Gallo R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54 (1979) 713-733
38. 3 correlates with reduced rate of maturation of DNA replication intermediates. Cancer Res. 51 (1991) 3451-3455
39. 3. J. Natl. Cancer Inst. 89 (1997) 1199-1206
40. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19 (1991) 2499
41. 3 target genes. Mol. Endocrinol. 19 (2005) 2685-2695
42. Matheny S.A., Chen C., Kortum R.L., Razidlo G.L., Lewis R.E., and White M.A. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 427 (2004) 256-260
43. Ory S., and Morrison D.K. Signal transduction: implications for Ras-dependent ERK signaling. Curr. Biol. 14 (2004) R277-R278
44. Yam L.T., Li C.Y., and Crosby W.H. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 55 (1971) 283-290
45. Yu F.L. Selective inhibition of rat liver nuclear RNA polymerase II by actinomycin D in vivo. Carcinogenesis 1 (1980) 577-581
46. Sakata Y., Yoshioka W., Tohyama C., and Ohsako S. Internal genomic sequence of human CYP1A1 gene is involved in superinduction of dioxin-induced CYP1A1 transcription by cycloheximide. Biochem. Biophys. Res. Commun. 355 (2007) 687-692
47. Lau L.F., and Nathans D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 1182-1186
48. 3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators. J. Biol. Chem. 275 (2000) 16506-16512
49. 3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia). J. Bone Miner. Res. 7 (1992) 457-463
50. 3-induced HL-60 cell differentiation. J. Biol. Chem. 269 (1994) 4070-4077
51. 3-induced differentiation of HL60 cells. J. Cell. Biochem. 80 (2001) 471-482
52. Marcinkowska E. Evidence that activation of MEK1,2/erk1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells. AntiCancer Res. 21 (2001) 499-504
53. 3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway. J. Cell. Biochem. 98 (2006) 590-617
54. Buck M., Poli V., Hunter T., and Chojkier M. C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol. Cell 8 (2001) 807-816
55. Pan Z., Hetherington C.J., and Zhang D.E. CCAAT/enhancer-binding protein activates the CD14 promoter and mediates transforming growth factor beta signaling in monocyte development. J. Biol. Chem. 274 (1999) 23242-23248
56. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
57. 3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway. J. Cell. Physiol. 204 (2005) 964-974
58. Nguyen A., Burack W.R., Stock J.L., Kortum R., Chaika O.V., Afkarian M., Muller W.J., Murphy K.M., Morrison D.K., Lewis R.E., McNeish J., and Shaw A.S. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol. Cell. Biol. 22 (2002) 3035-3045
59. Dekker J. The three 'C's of chromosome conformation capture: controls, controls, controls. Nat. Methods 3 (2006) 17-21
60. Saramaki A., Banwell C.M., Campbell M.J., and Carlberg C. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res. 34 (2006) 543-554
61. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., and Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9 (1994) 3397-3406
62. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10 (1996) 142-153
63. 3-responsive regions in its promoter. Nucleic Acids Res. 33 (2005) 2440-2451
64. 3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol. Cell. Endocrinol. 142 (1998) 57-65
65. 3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol. Endocrinol. 16 (2002) 1243-1256
66. Peng X., Mehta R., Wang S., Chellappan S., and Mehta R.G. Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells. Cancer Res. 66 (2006) 7361-7369
67. Campbell M.J., and Adorini L. The vitamin D receptor as a therapeutic target. Expert Opin. Ther. Targets 10 (2006) 735-748